Silvergate Pharmaceuticals, Inc., focused on the development and commercialization of innovative and safe medicines for children, today announced the availability by prescription of Epaned(tm) (enalapril maleate Powder for Oral Solution) to treat hypertension (high blood pressure) in people older than one month. Enalapril is one of the most commonly prescribed medicines in the United States to treat high blood pressure.

Approved by the FDA in August 2013, Epaned is specially formulated as a flavored liquid solution to appeal to children and people who have difficulty swallowing enalapril tablets. Many medicines are tested and developed for adults, leaving doctors and pharmacies to adjust adult doses for pediatric use. Approximately half of the prescription drugs commonly given to children do not have information on appropriate pediatric doses on their labels.1 Epaned is a powder form of enalapril that a pharmacist will use to make an oral solution so that children will no longer have to rely on adult tablets being made into a suspension.

"We're pleased to launch Epaned so quickly after receiving FDA approval," said Frank Segrave, President & CEO, Silvergate Pharmaceuticals, Inc. "Silvergate is happy to take the lead in developing FDA-approved medicines for children - an area of drug development that is often overlooked."

Epaned is available through an extensive network of pharmacies and may be eligible for reimbursement by most private insurance plans and state Medicaid programs. For additional information on how to obtain Epaned, please call 1-855-379-0382 or visit www.SilvergatePharma.com<http://www.SilvergatePharma.com/>.